ProShares To Launch Five New ETFs

Mar. 15, 2010 4:46 PM ETFXI, FXP, CYXI, REK, SBM
Jim Trippon profile picture
Jim Trippon's Blog
756 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2008

Jim Trippon, CPA, is the editor-in-chief of China Stock Digest (http://www.chinastockdigest.com/), America's #1 performing China investment newsletter as ranked by Dow Jones - Hulbert Financial Digest. All of the stocks covered by China Stock Digest (http://www.chinastockdigest.com/) may be purchased by US investors in US based retail brokerage accounts. A professional investment manager, Trippon has worked extensively inside China, and maintains a permanent team of financial analysts in Hong Kong, Shanghai, and Beijing. He leads an annual China Investors Fieldtrip each October and his new book Becoming Your Own China Stock Guru (http://www.amazon.com/Becoming-Your-China-Stock-Guru/dp/047022312X/ref=si3_rdr_bb_product) was recently released by John Wiley & Sons.

ProShares To Launch Five New ETFs

ProShares To Launch Five New ETFs
About: ProShares ETF, ProShares, Nasdaq Biotechnology Index, Ultra Nasdaq Biotechnology ETF, UltraShort Nasdaq Biotechnology ETF, ProShares Short FTSE/Xinhua China 25, FTSE/Xinhua China 25 Index (NYSE: FXI), China-specific ETF, UltraShort FTSE/Xinhua China25 Proshares (NYSE: FXP), ProShares Short Real Estate ETF, Dow Jones U.S. Real Estate Index, the ProShares Short Basic Materials ETF, Dow Jones U.S. Basic MaterialsSM Index
 Bookmark and Share
ProShares, the largest issuer of inverse and leveraged exchange traded funds, is following up on its recent announcement of plans for seven new leveraged and inverse ETFs by announcing plans for five more related products. Combined, the two recent product announcements will take ProShares' ETF inverse and leveraged ETF over 100 products.

ProShares will introduce bullish and bearish ETFs that track the Nasdaq Biotechnology Index. The Ultra Nasdaq Biotechnology ETF is a double leveraged bullish play while the UltraShort Nasdaq Biotechnology ETF is the double leveraged bearish equivalent. Tickers for these ETFs were not disclosed.

The ETF issuer will also introduce the ProShares Short FTSE/Xinhua China 25, which will trade under the ticker "YXI." YXI will seek results that correspond to the daily inverse performance of the popular FTSE/Xinhua China 25 Index (NYSE: FXI), the most heavily traded China-specific ETF. ProShares already issues the UltraShort FTSE/Xinhua China25 Proshares (NYSE: FXP), which is double leveraged inverse play on FXI. YXI is not leveraged.

ProShares will also introduce the ProShares Short Real Estate ETF, which will trade under the ticker “REK.” REK will track the daily inverse performance Dow Jones U.S. Real Estate Index. Basic materials is the next stop for ProShares, which plans to introduce the ProShares Short Basic Materials ETF. This ETF will trade under the ticker “SBM” and attempt to deliver the deliver inverse performance of the Dow Jones U.S. Basic MaterialsSM Index. REK and SBM are not leveraged.

For more information about The ETF Profit Report, visit http://www.etfprofitreport.com.

Committed to your ETF Profits,

Jim Trippon
Editor
The ETF Profit Report



Disclosure: no positions

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.